HALCYGEN FILES IND WITH THE US FDA TO BEGIN CLINICAL
DEVELOPMENT AND REGISTRATION OF SUBAITRACONAZOLETM
Improved anti-fungal targeting $600m market.announcement is worth a read
HALCYGEN FILES IND WITH THE US FDA TO BEGIN CLINICALDEVELOPMENT...
Add to My Watchlist
What is My Watchlist?